UBS Group’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-773
| Closed | -$8K | – | 10454 |
|
|
2022
Q3 | $8K | Sell |
773
-5,110
| -87% | -$52.9K | ﹤0.01% | 7717 |
|
|
2022
Q2 | $58K | Buy |
5,883
+4,620
| +366% | +$45.5K | ﹤0.01% | 4801 |
|
|
2022
Q1 | $12K | Buy |
1,263
+175
| +16% | +$1.66K | ﹤0.01% | 7210 |
|
|
2021
Q4 | $11K | Buy |
1,088
+509
| +88% | +$5.15K | ﹤0.01% | 7602 |
|
|
2021
Q3 | $6K | Buy |
579
+294
| +103% | +$3.05K | ﹤0.01% | 7340 |
|
|
2021
Q2 | $3K | Sell |
285
-1,714
| -86% | -$18K | ﹤0.01% | 7775 |
|
|
2021
Q1 | $20K | Buy |
+1,999
| New | +$20K | ﹤0.01% | 6393 |
|